v3.26.1
Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash and cash equivalents $ 447,453 $ 6,883,845 $ 3,198,682 $ 10,651,644
Accumulated deficit (54,508,221)   $ (49,936,598)  
Net Income (loss) (4,571,623) $ (3,698,414)    
Net cash used in operations 2,508,341      
Working capital $ 1,521,955      
Non- affiliate [Member]        
Description of remaining availability under sales agreement the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was approximately $39,144,000, which was calculated based on 11,184,116 outstanding shares of the Company’s common stock held by non-affiliates at a price of $3.50 per share, the closing price of our common stock on March 25, 2026, as reported on Nasdaq. Pursuant to General Instruction I.B.6 of Form S-3, or the “baby shelf” rules, in no event will we sell securities registered on our Form S-3 registration statement, including under our ATM, with a value of more than one-third of the aggregate market value of shares of our common stock held by non-affiliates in any 12-month period, so long as the aggregate market value of shares of our common stock held by non-affiliates is less than $75 million. After giving effect to the approximate $13,000,000 offering limit imposed by General Instruction I.B.6 of Form S-3 and deducting the shares sold within the preceding 12 months, approximately $3,700,000 shares of common stock